A monoclonal antibody cocktail developed by Regeneron reduced risk of developing symptomatic COVID-19 by 81% in household contacts living with a positive case, company said.
Antibody cocktail helps prevent coronavirus infections in same households
Live Science - 12 Apr 2021 21:14
A monoclonal antibody cocktail developed by Regeneron reduced risk of developing symptomatic COVID-19 by 81% in household contacts living with a positive case, company said.
Share this Article
Recommended